These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4632353)

  • 21. Behavioral effects of methamphetamine and -methyltyrosine in the rat.
    Evans HL
    J Pharmacol Exp Ther; 1971 Jan; 176(1):244-54. PubMed ID: 5569634
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of d-amphetamine and ethanol on responding of squirrel monkeys maintained under fixed-ratio schedules of food presentation and stimulus-shock termination.
    Katz JL; Barrett JE
    Pharmacol Biochem Behav; 1978 Jan; 8(1):35-9. PubMed ID: 415314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facilitation of avoidance acquisition in the rat by ethanol and its abolition by alpha methyl p-tyrosine.
    Chesher GB
    Psychopharmacologia; 1974; 39(1):87-95. PubMed ID: 4153853
    [No Abstract]   [Full Text] [Related]  

  • 24. Responding maintained by cocaine or d-amphetamine under fixed-interval schedules in baboons.
    Bradford LD; Griffiths RR
    Drug Alcohol Depend; 1980 May; 5(5):393-400. PubMed ID: 6768538
    [No Abstract]   [Full Text] [Related]  

  • 25. Reversal of alpha-methyltyrosine-induced behavioural depression with dihydroxyphenylalanine and amphetamine.
    Moore KE; Rech RH
    J Pharm Pharmacol; 1967 Jun; 19(6):405-7. PubMed ID: 4382374
    [No Abstract]   [Full Text] [Related]  

  • 26. Shuttlebox Sidman avoidance in rhesus monkeys: day of week and amphetamine effects.
    Rush DK
    Pharmacol Biochem Behav; 1986 Jul; 25(1):145-8. PubMed ID: 3749221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impairment by d-amphetamine of delayed matching performance in monkeys.
    Glick SD; Jarvik ME
    J Pharmacol Exp Ther; 1969 Sep; 169(1):1-6. PubMed ID: 4979681
    [No Abstract]   [Full Text] [Related]  

  • 28. Differential effects of amphetamine and scopolamine on matching performance of monkeys with lateral frontal lesions.
    Glock SD; Jarvik ME
    J Comp Physiol Psychol; 1970 Nov; 73(2):307-13. PubMed ID: 4992747
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of D-amphetamine and physostigmine upon acquisition and retrieval in a single trial learning task.
    Bohdanecky Z; Jarvik ME
    Arch Int Pharmacodyn Ther; 1967 Nov; 170(1):58-65. PubMed ID: 6056593
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of d-amphetamine and illumination on behaviors of the squirrel monkey.
    Lowther WR; Isaac W
    Psychopharmacology (Berl); 1976 Nov; 50(3):231-5. PubMed ID: 826967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that the CCENTRAL ACTION OF (+)-amphetamine is mediated via catecholamines.
    Hanson LC
    Psychopharmacologia; 1967; 10(4):289-97. PubMed ID: 5592154
    [No Abstract]   [Full Text] [Related]  

  • 32. Permanent facilitation of avoidance behavior by d-amphetamine and scopolamine.
    Barrett RJ; Leith NJ; Ray OS
    Psychopharmacologia; 1972; 25(4):321-31. PubMed ID: 5051145
    [No Abstract]   [Full Text] [Related]  

  • 33. Morphine enhancement of shuttle avoidance prevented by alpha-methyltyrosine.
    Davis WM; Smith TP
    Psychopharmacologia; 1975 Oct; 44(1):95-7. PubMed ID: 1197583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral variables affecting the development of amphetamine tolerance.
    Schuster CR; Dockens WS; Woods JH
    Psychopharmacologia; 1966; 9(2):170-82. PubMed ID: 5983915
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of ECT on dopaminergic and noradrenergic mechanisms. I. Effect on the behavioural changes induced by reserpine, alpha-methyl-p-tyrosine or amphetamine.
    Papeschi R; Randrup A; Lai S
    Psychopharmacologia; 1974 Feb; 35(2):149-58. PubMed ID: 4856059
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of administration regime on the psychotomimetic properties of d-amphetamine in the squirrel monkey (Saimiri sciureus).
    Sams-Dodd F; Newman JD
    Pharmacol Biochem Behav; 1997 Mar; 56(3):471-80. PubMed ID: 9077585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral effects of separate and combined administration of naloxone and d-amphetamine.
    Holtzman SG
    J Pharmacol Exp Ther; 1974 Apr; 189(1):51-60. PubMed ID: 4823299
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative recovery following simultaneous- and successive-stage frontal brain damage in mice.
    Glick SD; Zimmerberg B
    J Comp Physiol Psychol; 1972 Jun; 79(3):481-7. PubMed ID: 4341017
    [No Abstract]   [Full Text] [Related]  

  • 39. Facilitating effects of some chlorpromazine-D-amphetamine mixtures on avoidance learning.
    Del Río J
    Psychopharmacologia; 1971; 21(1):39-48. PubMed ID: 5567290
    [No Abstract]   [Full Text] [Related]  

  • 40. Behavioral and neuropharmacological analysis of amphetamine and 2,5-dimethoxy-4-methylamphetamine in rats.
    Tilson HA; Baker TG; Chamberlain JH
    Psychopharmacologia; 1975 Nov; 44(3):229-39. PubMed ID: 1208759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.